Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

11-01-2024(Thu) 10-01-2024(Wed) 09-01-2024(Tue) 08-01-2024(Mon) 05-01-2024(Fri)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
8 Mar, 2021 (Monday)

            
IMAX CHINA(1970)
Analysis¡G
IMAX China (1970) recorded a loss for the financial year ended 31 December 2020, mainly due to decline in gross box office as a result of temporary theatre closure amid the COVID-19 pandemic and the lack of major Hollywood films. As the pandemic has been successfully brought under control in China, audiences are eager to return to the cinema. In the early months of 2021, China box office has already surpassed RMB15 billion - not only continuing to recover, but breaking records. On behalf of the Board, IMAX China announces a proposed final dividend of US$0.02 per share, consistent with prior years in absolute terms. As business returns to normalcy in 2021, the Group also announced an increase in its dividend payout ratio from 33% of net income during 2017 to 2019 to 50% from 2021 onwards, underscoring confidence in its business, the continued recovery of the entertainment industry and the future cash flow generation ability of its network. (I do not hold the above stock)
Strategy¡G
Buy-in Price: $16.00, Target Price: $19.00, Cut Loss Price: $14.50


SA(601021.CH)
Analysis¡G
With the acceleration of the vaccination process, it is expected that in 2021, residents` life and travel will return to normal, and the demand for air transportation will be gradually restored. Spring Air is the leader of China`s low-cost airlines, and its unit operating cost is 32%-37% lower than that of the three major airlines, with a significant cost advantage. China`s low-cost airlines started late, are still in the early stages of development, and have a low penetration rate. With the diversification of residents` travel needs, the market potential is gradually emerging.
Strategy¡G
Buy-in Price: RMB59.00, Target Price: RMB70.00, Cut Loss Price: RMB53.00



Maoyan Entertainment (1896.HK) - The total movie box office during 2021 Chinese New Year hits a record high, the Chinese film industry recovers in an orderly manner

Investment Summary

The movie box office for 2020 was RMB 20.3 billion, which is in line with our previous expectation

Affected by the epidemic, all of the cinemas in China was temporarily suspended from January 24, 2020 to July 19, 2020, and only started gradually reopened on the 20th of July. According to the data from Maoyan Professional Edition, the total movie box office of China in 2020 was RMB 20.3 billion, down 68% yoy, which is in line with our previous expectations.

The total movie box office during 2021 Chinese New Year reached RMB 7.8 billion and hit a record high

The total movie box office during 2021 Chinese New Year was up by 32.47% yoy, reaching RMB 7.8 billion and hitting a record high. During the Chinese New Year holiday, the company has participated in 5 major films as either producer or distributor or both. These 5 films are Hi Mom (§A¦n,§õ·Ø­^), Detective ChinaTown 3 (­ð¤Hµó±´®×3), A Writer's Odyssey (¨ë±þ¤p»¡®a), Boonie Bears: The Wild Life (ºµ¥X¨S¡P¨g³¥¤j³°) and The Yinyang Master (¨Í¯«¥O). As of 23rd February, the box office rankings of these 5 movies were 1st , 2nd , 4th , 7th and 11th respectively, with a total box office of RMB 9.93 billion. Hi Mom (§A¦n,§õ·Ø­^) directed by Jia Ling is one of the dark horses among all the high-quality movies during the Chinese New Year holiday. According to Maoyan Professional Edition, as of February 23, the total box office of Hi Mom (§A¦n,§õ·Ø­^) reached RMB 4.31billion, with a forecast box office is RMB 5.22 billion. Hi Mom (§A¦n,§õ·Ø­^) currently ranked fourth on the box office rankings of Chinese film history. Hi Mom (§A¦n,§õ·Ø­^) has a Maoyan rating of 9.5/10, and more than 88% of the audience have given a 5-star rating to the movie, both of which ranked 1st among all movies during the same period. As the lead publisher and one of the main producer of Hi Mom (§A¦n,§õ·Ø­^), the company is expected to receive a relative high box office share as revenue.

As of February 23, 2021, the total box office of Chinese films has reached RMB 14.4 billion, and the total box office has already reached 71% of that of 2020. It can be seen that even under the policy of restricting attendance in cinemas, the recovery of Chinese movie industry remains strong. We expect the total box office in 2021 to return to the level prior the pandemic. As the leading movie ticketing platform in China (According to the Maoyan Professional Edition, the movie tickets sold through Maoyan platform have accounted for about 60% of the total during the Chinese New Year holiday), the company's earnings in 2021 will be substantially restored.

Valuation and Investment Thesis

We continue to be optimistic about the company's strategies in different entertainment formats and the company's ¡§TenMao Alliance¡¨ with Tencent. We believe that the main future growth driver of the company will come from the entertainment content sector, while the movie ticketing sector will provide the company with a stable cash flow for investment in different entertainment formats.

After considered that 1) the pandemic has a greater impact to the movie industry in China than we previously forecasted 2) the delay in production projects 3) the total impairment provision recognized by the company in FY2020 is expected to be ranged between RMB 350-420 million, we cut our 2020E/2021E/2022E revenue to RMB 1.39/4.46/5.20 billion from RMB 1.58/5.17/6.13 billion and cut our 2020E/2021E/2022E Non-GAAP net income to RMB -0.42/0.83/1.09 billion from RMB 0.08/0.98/1.30 billion. Since the sector is recovering in an orderly manner with a clearer prospect, we raise our 2021 target Non-GAAP PE to 22x and raise our TP to HKD 19.16, with respective 2020/2021/2022 Non-GAAP PE at NA/22.0x/16.8x. We upgrade to BUY rating. (Market closing price as of 3rd March) (exchange rate: RMB 0.85/HKD)

Risk

1) Pandemic broke out again in China

2) Business extension progress slower than expected

3) The film industry recovers slower than expected

4) The box office of company's productions is worse than expected

Financials

Click Here for PDF format...




Recommendation on 8-3-2021
RecommendationBuy
Price on Recommendation Date$ 14.800
Suggested purchase priceN/A
Target Price$ 19.160
Writer Info
Kevin Chiu
(Research Analyst)
Tel: +852 2277 6514
Email:
kevinchiu@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2021 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]